Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Outcomes in Patients With Primary Aldosteronism After Treatment

NCT04428827 is registered in ClinicalTrials.gov with Changi General Hospital as lead sponsor.

NCT NCT04428827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04428827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Outcomes in Patients With Primary Aldosteronism After Treatment
Lead sponsor
Changi General Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2016
Completion date
July 30, 2022
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenalectomy; status, cardiovascular morbidity, chronic renal disease, hypokalemia, mineralocorticoid antagonists [aldosterone antagonists] causing adverse effects in therapeutic use, mineralocorticoid excess, primary aldosteronism, primary aldosteronism due to adrenal hyperplasia (bilateral), primary aldosteronism due to aldosterone producing adenoma